ARCHIVES

Two Court Rulings Conflict In Paclitaxel Patent Battle.

This article is from The Cancer Letter archive.

Vol. 28 No. 03 | January 18, 2002

Download PDF Visit The Full Archive

Related Articles

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

Blochs to Sponsor “Fighting Cancer”

May 9, 1986

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

December 5, 1975

In Brief: Mauer Resigns St. Jude Director; Breslow Named DRCCA Board Chairman; Senate Considers Line Items

August 20, 1982

Time-Out For A New Sense Of Cooperation, Urgency.

January 21, 2000

ASCO Annual Report Names Significant Clinical Research Advances Of Past Year

December 25, 2009